About Us

Visgo is developing best in class products to treat joint diseases, such as osteoarthritis. These products will be locally delivered using the Company’s proprietary, joint friendly delivery platform to release drugs over time. Its first product, VG201, will deliver an NSAID by sustained release for the treatment of osteoarthritis pain, and is now in preclinical testing.

Contact Us

Jeanne M. Bertonis, CEO
jbertonis@visgotx.com